A taxonomy of preventability of overdose death: a multi-method study

Document type
Report
Author(s)
Hickman, Matthew; Carrivick, Sandra; Cusick, Linda
Publisher
NHS National Treatment Agency for Substance Misuse
Date of publication
2 April 2007
Series
Research briefing; 23
Subject(s)
Substance Misuse
Collection
Social welfare
Material type
Reports

Download (443KB )

The aims of this study were to provide a description and initial taxonomy of overdose deaths in London. Firstly, coronial files from seven of the eight coroners’ courts in London were examined to identify drug-related poisonings that took place or went to inquest in 2003 and reported a positive toxicology, or circumstances of death that implicated heroin, cocaine, methadone, MDMA, amphetamine or dihydrocodeine. 151 deaths were determined or suspected as drug-related poisonings, which represents approximately 75 per cent of all drug-related deaths involving illicit drugs or opiates in London in 2003. Both qualitative data, from witness statements and reports, and quantitative data were extracted from the files. In addition, 61 narratives of overdose death were collected to discover naturally occurring witness accounts of overdose death to compensate for the incomplete information available from coroners’ records. Finally, a panel of expert drug user analysts checked the plausibility of the data in a sample of the witness statements and narratives, and also provided insight on the ways drug users might interpret the accounts. The study found that the majority of deaths were in subjects with a history of opiate use and drug dependence, and drug-related deaths are on average older and more likely to be male than problem drug users in treatment or in the population. In approximately one-third of cases there was evidence of recent release from prison or current substitute prescription. The study concluded that opportunities do exist to prevent overdose deaths and many of these depend on improved communication between drug users, and between service providers and drug users, with specific reference to assessing the risk of altered tolerance, norms of sharing and scoring, assisted injecting, checking vital signs during drug use, knowing how to prioritise actions once signs of trouble arise, prevention literature including information on stimulant overdose signs of trouble, specific information on assessing drug quality and polydrug use risks, especially for mixing respiratory depressant drugs and stimulants, and detailed written information on all drugs literature being available in all languages. Consideration should be given to campaigns that raise awareness of signs of overdose, but also seek to encourage a shared responsibility or duty of care for other drug users.

Related to NHS National Treatment Agency for Substance Misuse

Mental healthcare: a capitated approach to payment with outcomes and risk share components

This document is intended for all organisations involved in commissioning or delivering new care models. It is aimed at providers and commissioners who are interested in more information on outcomes-based

Multilateral gain/loss sharing: a financial mechanism to support collaborative service reform

Across the health and care sector, there is a move towards offering better co-ordinated services through new networked and integrated models of care. The launch of the ‘NHS Five Year Forward View’ has

Healthcare UK overview and annual review: 2014/15

Healthcare UK is a joint initiative of the Department of Health, UK Trade and Investment, and NHS England. It helps UK healthcare providers to do more business overseas. It does this by promoting the

Mental health staffing framework

This new framework for senior mental health professionals is designed to ensure that the right people with the right skills are recruited to the right in-patient mental health settings. It is not intended

More items related to this publisher